Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20090801002266N12
IRCT20090801002266N12
Recruiting
Phase 3

Efficacy of add on buprenorphine vs. placebo on reduction of relapse among people with Met Amphetamine dependency during Matrix program

Esfarayen University of Medical Sciences0 sites40 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsMethamphetamine use disorder.Mental and behavioral disorders due to use of other stimulants, including caffeineF10-F19

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Methamphetamine use disorder.
Sponsor
Esfarayen University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
6 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Esfarayen University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •1\) People 18\-60 years old 2\)Having the DSM\-V criteria for methamphetamine use disorder 3\) It is dependent only on methamphetamine 4\) No pregnancy and lactation

Exclusion Criteria

  • •1\)Any psychiatric disorder that require hospitalization 2\) Medical condition that interfere with participating in the study 3\)Any side effect that interfere with continuation of buprenorphin

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Comparing of Buprenorphine with Placebo in Reducing Methamphetamine CravingMethamphetamine Dependency.Mental and behavioural disorders due to use of other stimulants, including caffeine.Dependence syndrome
IRCT201406017841N6Isfahan University of Medical Sciences, Behavioral Sciences Research Center40
Recruiting
Phase 4
Efficacy of different doses of Buprenorphine on reduction of withdrawal symptoms, anxiety, depression and suicidal thoughtsOpioid dependency.Mental and behavioral disorders due to use of opioids
IRCT2017071925160N6Shiraz University of Medical Sciences60
Completed
Not Applicable
The effects of bupropion on negative symptoms in schizophreniaegative symptoms in schizophrenia.
IRCT2013100114850N1Yazd medical science university of shahid sadughi40
Not yet recruiting
Phase 3
To compare the effects of buprenorphine with levobupivacaine and buprenorphine with ropivacaine in epidural anaesthesia
CTRI/2021/05/033880Pruthvi D Hiremath
Not yet recruiting
Phase 3
Effect of Bupropion versus placebo on the management of fatigue caused by multiple sclerosisMultiple sclerosis.Multiple sclerosis
IRCT20120215009014N465Hamedan University of Medical Sciences46